AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand [BNN Bloomberg (Canada)]
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: BNN Bloomberg
The marketing authorization for the vaccine, Vaxzevria, in the European Union was withdrawn at the company's request this week as the vaccine is no longer manufactured or supplied, Astra said in a statement. The decision was not related to safety reasons, it said. Astra's vaccine, which was developed with Oxford University, was initially offered on a not-for-profit basis and was seen as a win for Britain, with then-Prime Minister Boris Johnson publicly receiving his first dose. However, the rollout was plagued by concerns about its efficacy and safety, starting with French President Emmanuel Macron calling it “quasi-ineffective” in older adults shortly after it was approved in the EU. The vaccine, which didn't require ultra-cold storage as some of the rival Covid-19 shots did, was seen as a good option to inoculate large portions of the globe. More than 3 billion doses were supplied. After Macron's comments, a bigger blow came when regulators began investigating the vaccine's l
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024GlobeNewswire
- BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Evercore ISI. They set an "inline" rating and a $100.00 price target on the stock.MarketBeat
- We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year [Yahoo! Finance Canada]Yahoo! Finance Canada
- We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year [Yahoo! Finance]Yahoo! Finance
BNTX
Earnings
- 5/6/24 - Miss
BNTX
Sec Filings
- 5/17/24 - Form 6-K
- 5/6/24 - Form 6-K
- 5/6/24 - Form 6-K
- BNTX's page on the SEC website